answers to your
Creativ-Ceutical will be at ISPOR Asia Pacific in Singapore!
Meet us at our booth #13 to discuss our presentations on varions topics such as :
Creativ-Ceutical will be at ISPOR International in Washington!
Meet us at our booth #27 to discuss our presentations on varions topics such as :
Creativ-Ceutical will be at ISPOR Europe in Milan !
Meet us at our booth #405 to discuss our presentations on varions topics such as :More
Pr. Mondher Toumi of the Aix Marseille University and Founder and CEO of Creativ-Ceutical was invited to participate at the 5th Annual European Pricing Platform on September 21st – 23rd in Montreux, SwitzerlandMore
Creativ-Ceutical presented a scientific contribution on patients’ preference in asthma and chronic obstructive pulmonary disease at the iHEA 11th World Congress.More
Take a look at our scientific contributions to NSFA Congress in Biarritz, FranceMore
Be ready for future of HTA health economics landscape in France and discover the French ICER threshold.More
Creativ-Ceutical and Continuum Clinical form Strategic Alliance
Industry leaders in developing evidence of medical product value collaborate to serve clients.
Understand the difference between HAS and NICE health economic requirements.
Identify the grounds for differentiation and be ready for successful submission.
“ The innovative model developed for pharmaceutical expenditure forecast allowed to inform the European Commission on how Member States' public pharmaceutical expenditures are likely to evolve over the next few years, both from medicinal products going off patent and from new patent medicinal products.”EU Commission DG SANCO
“Creativ-Ceutical has helped Air Liquide Santé International to assess new indications for long-known molecule. Hard-workers and based on strict methodology, they have been great consultants and proven highest added value to internal thinking. ”International Medical Director, Air Liquide Santé International World Business Line